Genomic and epigenomic integration identifies a prognostic signature in colon cancer

Clinical Cancer Research

Volumn 17, Issue 6, 2011, Pages 1535-1545

  Yi, Joo Mi ^a,h   Dhir, Mashaal ^b   Van Neste, Leander ^c,d   Downing, Stephanie R ^b   Jeschke, Jana ^b   Glockner, Sabine C ^b   Calmon, Marilia De Freitas ^b   Hooker, Craig M ^a   Funes, Juan M ^c,e   Boshoff, Chris ^c,e   Smits, Kim M ^f   Van Engeland, Manon ^f   Weijenberg, Matty P ^f   Iacobuzio Donahue, Christine A ^b   Herman, James G ^a   Schuebel, Kornel E ^g   Baylin, Stephen B ^a   Ahuja, Nita ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GHENT UNIVERSITY   (Belgium)

^d MDxHealth   (Belgium)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^h Dongnam Institute of Radiological and Medical Science   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CD109 GENE; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; EVL GENE; EXTRACELLULAR MATRIX; FEMALE; FLNC GENE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENOMICS; HUMAN; HUMAN TISSUE; IGFBP3 GENE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS;

AGED; CELL LINE, TUMOR; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; FEMALE; GENOMICS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 79952717245     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-2509     Document Type: Article

References (43)

1. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006;314:268-74. (Pubitemid 44571966)
2. Wood LD, Parsons DW, Jones S, Lin J, Sj€oblom T, Leary RJ, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007;318:1108-13. (Pubitemid 350134889)
3. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007;128:683-92. (Pubitemid 46273572)
4. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349: 2042-54. (Pubitemid 37448928)
5. Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, et al. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med 2008;358:1118-28. (Pubitemid 351398486)
6. Kim MS LJ, Sidransky D. DNA methylation markers in colorectal cancer. Cancer Metastasis Rev 2010;29:181-206.
7. Schuebel KE, Chen W, Cope L, Gl€ockner SC, Suzuki H, Yi JM, et al. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 2007;3:1709-23. (Pubitemid 47510263)
8. Chan TA, Glöckner SC, Yi JM, Chen W, Van Neste L, Cope L, et al. Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis. PLoS Med 2008;5:823-38.
9. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002;2:442-54.
10. DeClerck YA, Mercurio AM, Stack MS, Chapman HA, Zutter MM, Muschel RJ, et al. Proteases, extracellular matrix, and cancer: a workshop of the path B study section. Am J Pathol 2004;164:1131-9. (Pubitemid 38387779)
11. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer 2005;5:744-9. (Pubitemid 41486367)
12. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the cross-roads of development and tumor metastasis. Dev Cell 2008;14:818-29. (Pubitemid 351757205)
13. Van Den Brandt PA, Goldbohm RA, Van 'T Veer P, Volovics A, Hermus RJJ, Sturmans F. A large-scale prospective cohort study on diet and cancer in the Netherlands. J Clin Epidemiol 1990;43:285-95. (Pubitemid 20074213)
14. Takai D, Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22.Proc Natl Acad Sci U S A2002;99:3740-5.
15. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008;321:1807-12.
16. Lane RP, Chen X-N, Yamakawa K, Vielmetter J, Korenberg JR, Dreyer WJ. Characterization of a highly conserved human homolog to the chicken neural cell surface protein bravo/Nr-CAM that maps to chromosome band 7q31. Genomics 1996;35:456-65. (Pubitemid 26270011)
17. Beck K, Hunter I, Engel J. Structure and function of laminin: anatomy of a multidomain glycoprotein. FASEB J 1990;4:148-60.
18. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Can Inst 1997;89:1260-70.
19. FinnsonKWTB, Liu K, Marcoux A, Lepage P, Roy S, Bizet AA, Philip A. Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes. FASEB J 2006;20:1525-7.
20. Tian L SM, Ning L, Van Lint P, Nyman-Huttunen H, Libert C, Itohara S, et al. Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage. J Cell Biol 2007;178:687-700. (Pubitemid 47267279)
21. Bachman KE, Herman JG, Corn PG, Merlo A, Costello JF, Cavenee WK, et al. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Cancer Res 1999;59:798-802. (Pubitemid 29086729)
22. Galm O, Suzuki H, Akiyama Y, Esteller M, Brock MV, Osieka R, et al. Inactivation of the tissue inhibitor of metalloproteinases-2 gene by promoter hypermethylation in lymphoid malignancies. Oncogene 2005;24:4799-805. (Pubitemid 41076297)
23. Ibanez de Cac eres I, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, Cairns P. Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res 2006;66:5021-8.
24. Ulazzi L SS, Miotto E, Veronese A, Angusti A, Gafá R, Manfredini S, et al. Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer. Mol Cancer 2007;6:17.
25. CheethamS, Tang MJ, Mesak F, Kennecke H, Owen D, Tai IT. SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-20-deoxycytidine to increase SPARC expression and improve therapy response. Br J Cancer 2008;98:1810-9. (Pubitemid 351748842)
26. Chicoine E, Esteve P-O, Robledo O, Van Themsche Ci, Potworowski EF, St-Pierre Y. Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression. Biochem Biophys Res Commun 2002;297:765-72. (Pubitemid 35230316)
27. Mani SA, Guo W, Liao M-J, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-15. (Pubitemid 351636299)
28. Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343-51. (Pubitemid 38702845)
29. Kuebler JP, Wieand HS, O'Connell MJ, Smith RE, Colangelo LH, Yothers G, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol 2007;25:2198-204. (Pubitemid 46954643)
30. Mehrotra J, Ganpat MM, Kanaan Y, Fackler MJ, McVeigh M, Lahti- Domenici J, et al. Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women. Clin Cancer Res 2004;10:2052-7. (Pubitemid 38375566)
31. Chan AO, Soliman AS, Zhang Q, Rashid A, Bedeir A, Houlihan PS, et al. Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countries. Clin Cancer Res 2005;11:8281-7. (Pubitemid 41746938)
32. Pelikan S, Moskowifz M. Effects of lead time, length bias, and false-negative assurance on screening for breast cancer. Cancer 1998;71:1998-2005. (Pubitemid 23068548)
33. Meguid RA SM, Wolfgang CL, Chang DC, Ahuja N. Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol 2008;15:2388-94.
34. Barry I. Are there two sides to colorectal cancer? Int J Cancer 2002;101:403-8.
35. Annika L. Different mechanisms in the tumorigenesis of proximal and distal colon cancers. Curr Opin Oncol 2001;13:63-9.
36. Sugai T, Habano W, Jiao Y-F, Tsukahara M, Takeda Y, Otsuka K, et al. Analysis of molecular alterations in left- and right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis: proposal for new molecular profile of colorectal carcinomas. J Mol Diagn 2006;8:193-201. (Pubitemid 43811242)
37. Benedix F KR, Meyer F, Schmidt U, Gastinger I, Lippert H; Colon/rectum carcinomas (primary tumor) study group. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 2010;53:57-64.
38. Yamada PM, Lee K-W. Perspectives in mammalian IGFBP-3 biology: local vs. systemic action. Am J Physiol Cell Physiol 2009:296;C954-76.
39. Flood A MV, Pfeiffer R, Kahle L, Rosen CJ, Lanza E, Schatzkin A. Serum concentrations of insulin-like growth factor and insulin-like growth factor binding protein 3 and recurrent colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2008;17: 1493-8.
40. de Maat MFG, van de Velde CJH, van der Werff MPJ, Putter H, Umetani N, Klein-Kranenbarg EM, et al. Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence. J Clin Oncol 2008;26:2327-35.
41. Umetani N, Takeuchi H, Fujimoto A, Shinozaki M, Bilchik AJ, Hoon DSB, Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis. Clin Cancer Res 2004;10:7475-83. (Pubitemid 39557508)
42. Ben-Porath I,Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008;40:499-507. (Pubitemid 351601215)
43. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell 2007;128:669-81. (Pubitemid 46273573)